[
  {
    "ts": null,
    "headline": "Jim Cramer on Cardinal Health: “I am a Believer”",
    "summary": "Cardinal Health, Inc. (NYSE:CAH) is one of the 11 stocks on Jim Cramer’s radar. Calling Cardinal Health, Inc.’s (NYSE:CAH) upcoming Investor Day a possible needle mover, Cramer said: “Now, Thursday brings some analyst meetings that could move the needle. Cardinal Health, we’ve had them on a couple of times, tells a terrific story about how […]",
    "url": "https://finnhub.io/api/news?id=c23d63b1631439ac0321089eeaed8a9155be524c1ee58b2440d169600d814101",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749670323,
      "headline": "Jim Cramer on Cardinal Health: “I am a Believer”",
      "id": 135202042,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Cardinal Health, Inc. (NYSE:CAH) is one of the 11 stocks on Jim Cramer’s radar. Calling Cardinal Health, Inc.’s (NYSE:CAH) upcoming Investor Day a possible needle mover, Cramer said: “Now, Thursday brings some analyst meetings that could move the needle. Cardinal Health, we’ve had them on a couple of times, tells a terrific story about how […]",
      "url": "https://finnhub.io/api/news?id=c23d63b1631439ac0321089eeaed8a9155be524c1ee58b2440d169600d814101"
    }
  },
  {
    "ts": null,
    "headline": "Cardinal Health Analyst Flags Fading Scale Gap, Sees Rising Edge in Specialty Growth",
    "summary": "BofA Securities analyst Allen Lutz reiterated the Buy rating on Cardinal Health, Inc. (NYSE:CAH), raising the price forecast from $165 to $170. Lutz noted that Cardinal Health is set to host its investor day in New York on June 12, where the company will offer an updated business outlook compared to its last investor event two years ago. With strong performance over the past two years and favorable industry dynamics—such as rising utilization and IRA-driven out-of-pocket cost changes—expectation",
    "url": "https://finnhub.io/api/news?id=e3ff7720f77b2f7493739e78e693c51a46664ef1351c9373065c9060d4ea9781",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749663837,
      "headline": "Cardinal Health Analyst Flags Fading Scale Gap, Sees Rising Edge in Specialty Growth",
      "id": 135202043,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "BofA Securities analyst Allen Lutz reiterated the Buy rating on Cardinal Health, Inc. (NYSE:CAH), raising the price forecast from $165 to $170. Lutz noted that Cardinal Health is set to host its investor day in New York on June 12, where the company will offer an updated business outlook compared to its last investor event two years ago. With strong performance over the past two years and favorable industry dynamics—such as rising utilization and IRA-driven out-of-pocket cost changes—expectation",
      "url": "https://finnhub.io/api/news?id=e3ff7720f77b2f7493739e78e693c51a46664ef1351c9373065c9060d4ea9781"
    }
  },
  {
    "ts": null,
    "headline": "2 Reasons to Like CAH and 1 to Stay Skeptical",
    "summary": "Since June 2020, the S&P 500 has delivered a total return of 100%. But one standout stock has nearly doubled the market - over the past five years, Cardinal Health has surged 193% to $154 per share. Its momentum hasn’t stopped as it’s also gained 31.2% in the last six months, beating the S&P by 31.9%.",
    "url": "https://finnhub.io/api/news?id=df225d2d096834d4f620414ab9affa7e012394b556fb417bd80286539359b7cb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749614469,
      "headline": "2 Reasons to Like CAH and 1 to Stay Skeptical",
      "id": 135180471,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Since June 2020, the S&P 500 has delivered a total return of 100%. But one standout stock has nearly doubled the market - over the past five years, Cardinal Health has surged 193% to $154 per share. Its momentum hasn’t stopped as it’s also gained 31.2% in the last six months, beating the S&P by 31.9%.",
      "url": "https://finnhub.io/api/news?id=df225d2d096834d4f620414ab9affa7e012394b556fb417bd80286539359b7cb"
    }
  }
]